secwatch / observer
8-K filed September 17, 2024, 7:59 PM ET ticker RVPH CIK 0001742927
other material confidence high sentiment neutral materiality 0.30

Reviva awards FY2023 bonuses: CEO $157,500, CFO $95,940, VP $77,376 in options

REVIVA PHARMACEUTICALS HOLDINGS, INC.

REVIVA PHARMACEUTICALS HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001437749-24-029392
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.